0001127602-21-019395.txt : 20210607
0001127602-21-019395.hdr.sgml : 20210607
20210607182343
ACCESSION NUMBER: 0001127602-21-019395
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210604
FILED AS OF DATE: 20210607
DATE AS OF CHANGE: 20210607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knell Michael Gunnar
CENTRAL INDEX KEY: 0001543779
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15943
FILM NUMBER: 211000730
MAIL ADDRESS:
STREET 1: BRUKER CORPORATION
STREET 2: 40 MANNING ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CENTRAL INDEX KEY: 0001100682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 061397316
FISCAL YEAR END: 1226
BUSINESS ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 781-222-6000
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC
DATE OF NAME CHANGE: 20000605
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19991208
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-06-04
0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL
0001543779
Knell Michael Gunnar
251 BALLARDVALE STREET
WILMINGTON
MA
01887
1
CSVP&Chief Accounting Officer
Common Stock
2021-06-04
4
M
0
388
109.34
A
4618
D
Common Stock
2021-06-04
4
M
0
735
144.67
A
5353
D
Common Stock
2021-06-04
4
M
0
404
179.66
A
5757
D
Common Stock
2021-06-04
4
S
0
1527
335.2364
D
4230
D
Stock Options (Right to Buy)
109.34
2021-06-04
4
M
0
388
0
D
2019-02-23
2023-02-23
Common Stock
388
855
D
Stock Options (Right to Buy)
144.67
2021-06-04
4
M
0
735
0
D
2020-02-22
2024-02-22
Common Stock
735
1471
D
Stock Options (Right to Buy)
179.66
2021-06-04
4
M
0
404
0
D
2021-05-29
2030-05-29
Common Stock
404
1212
D
This transaction was executed in multiple trades at prices ranging from $335.17 to $335.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Michael G. Knell
2021-06-07